Few studies have addressed the possible association between age at menarche and multiple sclerosis (MS), and results are conflicting. We studied this issue in a large prospective cohort study. The study cohort comprised 77,330 women included in the Danish National Birth Cohort (1996Cohort ( -2002. Information on menarcheal age was ascertained at the first interview, which took place in the 16th week of pregnancy. Women were followed for MS from the first interview to December 31, 2011. Associations between age at menarche and risk of MS were evaluated with hazard ratios and 95% confidence intervals using Cox proportional hazards regression models. Overall, 226 women developed MS during an average follow-up period of 11.7 years. Age at menarche among women with MS was generally lower than that among women without MS (Wilcoxon rank-sum test; P = 0.002). We observed an inverse association between age at menarche and MS risk. For each 1-year increase in age at menarche, risk of MS was reduced by 13% (hazard ratio = 0.87, 95% confidence interval: 0.79, 0.96). Early age at menarche appears to be associated with an increased risk of MS. The mechanisms behind this association remain to be established.
In order to investigate the potential association between age at menarche and risk of MS, we took advantage of data from a large Danish prospective cohort of more than 90,000 women and the nationwide Danish MS registry. In a supplementary analysis, we used data from the Copenhagen School Health Records Register, which includes detailed longitudinal health information on more than 300,000 schoolchildren.
METHODS The Danish National Birth Cohort
The present study was based on the Danish National Birth Cohort (DNBC; www.dnbc.dk), which includes 91,769 women who were pregnant during the period 1996-2002. DNBC data collection consisted of 4 computer-assisted telephone interviews, 2 prenatal interviews conducted during gestational weeks 16 and 30, and 2 postnatal interviews conducted when the child was 6 months and 1.5 years of age (21) . In the present study, we primarily used data from the first interview (interview 1), which included collection of detailed information about prepregnancy health, socioeconomic status, and lifestyle factors.
Exposure
According to information from interview 1, age at menarche was defined using the woman's recall of either her exact age at menarche (years; registered only in integers) or grade in school at the start of menstruation. We converted "third grade" to age 9 years, "fourth grade" to age 10 years, and so on (Table 1) .
MS outcomes
MS cases in the study cohort were identified in the Danish Multiple Sclerosis Registry (DMSR), which was formally established in 1956 in continuation of a nationwide MS surveillance study carried out a few years earlier (22) . The DMSR is based on notifications by all neurological departments in Denmark, 2 MS rehabilitation centers, and practicing neurologists, who send copies of discharge letters or medical records to the DMSR (23) . Since 1977 the DMSR has also collected information about MS patients from the Danish National Patient Register (NPR). In the DMSR, all received information about possible MS cases has been reviewed and classified by a neurologist. Diagnostic criteria and classifications of MS have changed over time due to the development of better diagnostic tools, such as magnetic resonance imaging scans. In the present study, we included cases fulfilling contemporary diagnostic criteria for MS as defined by Allison (until 1993), Poser (1994 Poser ( -2004 , and McDonald (2005 onwards) (23, 24) . In the DMSR, the date of diagnosis and the recalled date of the first symptoms of MS are recorded by calendar year. Consequently, in all of the analyses, we defined the date of diagnosis and the recalled date of first MS symptoms as July 1st in the relevant years recorded in the DMSR.
The Civil Registration System
Since 1968, every citizen of Denmark has been assigned a unique personal identification number in the Danish Civil Registration System. Among other things, this register contains continually updated information about vital status and residence, and it includes close to complete registration of all children of women born in Denmark since 1935 (25) . The personal identification number was used to identify persons in the DNBC and DMSR and provided a means of linkage between the 2 registers.
Covariates
It has been suggested that age at menarche is associated with parental socioeconomic status and childhood obesity and furthermore may have an influence on later obesity, smoking, alcohol habits (26, 27) , and reproductive factors such as age at first pregnancy and parity (28, 29) . All of these factors might also be associated with the risk of MS (30) (31) (32) (33) . Unfortunately, women in the DNBC were not asked about parental socioeconomic status or about prepregnancy smoking habits; thus, we had to use the woman's sociooccupational level and her smoking habits during pregnancy as markers of childhood socioeconomic status (34) and prepregnancy smoking habits (35) , respectively. Likewise, because of the lack of information about obesity in childhood, we used adult body mass index (BMI)-that is, body weight in kilograms divided by height in meters squared-as a proxy for childhood BMI, although the association between the two is not entirely clear (36) . Prepregnancy BMI (<18.5, 18.5-<25, 25-<30, or ≥30), prepregnancy weekly alcohol intake (0, 1-2, 3-4, 5-6, or ≥7 units/week), parity (0, 1, 2, or ≥3), and socio-occupational status were categorized according to information collected in interview 1 and smoking status (yes, no) according to interviews 1-3 (Table 1 ). For nulliparous women, age at first pregnancy was defined as age at interview 1 minus 16 weeks. For the remaining women, age at first pregnancy was defined as age at first childbirth minus 38 weeks according to information from the Civil Registration System.
Statistics
Each cohort member was followed from the date on which she completed interview 1 to the date of MS diagnosis, death, emigration, disappearance, or the end of follow-up (December 31, 2011), whichever came first. The distribution of age at menarche among women who developed MS was compared with that among women who remained free of MS by means of the Wilcoxon rank-sum test (2-sided test). Associations between age at menarche and MS risk were evaluated using hazard ratios and 95% confidence intervals in Cox proportional hazards regression models stratified by birth year and with age as the underlying time scale. Age at menarche was included in the model as a discrete variable (≤10, 11, 12, 13, 14, 15, or ≥16 years), an ordinal variable (early (≤11 years), intermediate (12-14 years) , or late (≥15 years) age at menarche), and a continuous variable. To examine whether the association between age at menarche and risk of MS was influenced by BMI, socioeconomic status, smoking, alcohol consumption, parity, or age at first pregnancy, we repeated the analysis including each of these covariates one by one in the Cox proportional hazards regression model.
The proportional hazards assumptions in the Cox regression model were explored by subdividing the underlying time scale, age, into different age intervals. Subsequently, we examined whether the association, that is, hazard ratios for the relationship between menarcheal age and MS, differed according to the different underlying age intervals of follow-up. Trend tests were carried out only after acceptance (P ≥ 0.05) of the corresponding model reduction from a categorical description to a linear description of the association between menarcheal age and MS risk. When estimating the linear trend-that is, the change in the hazard ratio for MS per additional 1-year increase in age at menarche-the whole spectrum of different ages at menarche, ranging from 7 years to 30 years (in integers), was included in the model.
Robustness analyses
In the primary analysis, the MS outcome was defined as the date of MS diagnosis according to registrations in the DMSR. In the first robustness analysis, we used date of first MS symptom as the MS outcome. Occurrence of the first symptom was determined by recall and might therefore have been subject to some uncertainty; nevertheless, it is considered closer to the true onset of MS. Although as many as 440-500 MS cases were registered annually in the DMSR from 2008 to 2011, the DMSR is considered complete only through 2009. The NPR has MS data available through 2011, but this register carries no information on the date of clinical onset of MS, and the diagnostic validity of MS diagnoses recorded in the NPR is considered slightly lower than that of diagnoses recorded in the DMSR (37) . Thus, in a second robustness analysis, we defined MS outcome as the date of the first hospital contact with an MS diagnosis in the NPR (International Classification of Diseases, Eighth Revision, code 340 for the period 1977-1993 and International Classification of Diseases, Tenth Revision, code G35 for the period 1994-2011). In third, fourth, and fifth robustness analyses, the hazard ratio for MS per additional 1-year increase in age at menarche was estimated in a Cox proportional hazards regression model excluding extreme values of age at menarche (<9 years and >19 years), using the date of diagnosis, first MS symptom, or first hospital contact with MS, respectively, as the MS outcome.
Supplementary analysis
When women in the DNBC were asked about age at menarche, they had to recall an event which for most of them had taken place at least 10 years prior to study entry. This could have led to imprecision in the data concerning menarcheal age. To address this issue, we used data from the Copenhagen School Health Records Register (38) . This register comprises historical records of annual school health examinations carried out among 350,445 children who were born between 1930 and 1983 and attended primary schools in the capital of Copenhagen. This data set contained selfreported information on age at menarche that was collected by school health physicians and nurses in the same year as menstruation began. As part of a previous study of MS (39) , records on MS cases and controls were obtained for 325,218 children born during the period 
RESULTS
Overall, 85,362 women in the DNBC completed interview 1. Women who either reported having MS at interview 1 (n = 68) or were registered with MS before entering the DNBC (n = 27) and women with missing information on any of the covariates were excluded, thus reducing the cohort to 77,330 women (Table 1) . Mean age at interview 1 was 29.9 years (standard deviation (SD), 4.3), and women were followed on average for 11.7 years (SD, 1.7). In total, 226 cases of MS were identified in the cohort during follow-up. The distribution of ages at menarche among women with MS differed statistically significantly from that among women without MS (Wilcoxon rank-sum test; P = 0.002), and mean age at menarche among MS cases was 13.0 years (SD, 1.5), as opposed to 13.3 years (SD, 1.4) among women without MS.
We observed an inverse association between age at menarche and risk of MS. The risk of MS was reduced by 13% (hazard ratio (HR) = 0.87, 95% confidence interval (CI): 0.79, 0.96) for each 1-year increase in age at menarche ( Table 2 ). Adjusting individually for BMI, socio-occupational status, age at first pregnancy, parity, smoking, and alcohol intake resulted in virtually identical estimates (hazard ratios for MS per 1-year increase in menarcheal age were all between 0.87 and 0.88). Including all of the above covariates in a multivariate analysis slightly reduced the HR estimate to reflect an 11% reduction in risk of MS per additional 1-year increase in menarcheal age (HR = 0.89, 95% CI: 0.81, 0.98) (results not shown).
Analyses using predefined categories of menarcheal age showed an increased MS risk (HR = 1.80, 95% CI: 1.05, 3.08) associated with early (age ≤11 years) as opposed to late (age ≥15 years) menarche (Table 2) . Estimates were similar in the robustness analyses using date of first MS symptom or date of first hospital contact with MS to define the date of MS outcomes ( Table 2 ). The hazard ratio for MS per additional 1-year increase in age at menarche was likewise practically unchanged in the analyses excluding women with extreme values of age at menarche (data not shown). In the supplementary analysis based on data from the cohort of girls with school health records, we observed an inverse association between age at menarche and risk of MS, although the association did not reach statistical significance. We found that for each 1-year increase in menarcheal age, the risk of MS decreased by 11% (odds ratio = 0.89, 95% CI: 0.70, 1.13) (Table 3 ) and that the mean age at menarche among MS cases was 13.1 years (SD, 1.1), as opposed to 13.2 years (SD, 1.1) among controls. Distributions of menarcheal age did not differ between cases and controls (Wilcoxon rank-sum test; P = 0.4).
DISCUSSION
We observed an inverse association between age at menarche and risk of MS in a prospective cohort study of 77,330 women. Specifically, for each 1-year increase in age at menarche, the risk of MS was reduced by 13%. Estimates were similar in the robustness analyses and in the supplementary analysis.
Few previous studies have addressed the relationship between age at menarche and risk of MS. In 1989, Operskalski et al. (16) carried out a case-control study based on 118 women with MS and an equal number of age-matched controls identified among female friends of the MS patients and found that MS cases were statistically significantly younger at menarche than controls (age 12.3 years vs. age 12.7 years). Similar results were seen in a Canadian case-control study carried out by Ramagopalan et al. (17) . They collected data on puberty by interviewing 5,493 MS cases and their 1,759 control spouses. Average age at menarche for the 4,472 female MS cases and the 658 female controls were 12.4 years and 12.6 years, respectively (P = 0.00017), with a 10% reduction in the relative risk of MS per 1-year increase in age at menarche (17) . Younger mean age at menarche among MS cases was also reported in a case-control study from the Faroe Islands (15) that included 23 MS cases (9 women) and 127 controls (68 women) identified among neighbors, siblings, spouses, or relatives (age 13.6 years vs. age 14.0 years). However, the difference did not reach statistical significance.
In contrast, in a French case-control study based on 46 female MS cases and 46 age-and residence-matched controls, Berr et al. (20) reported a higher mean age at menarche among MS cases compared with controls (13.5 years vs. 12.7 years; P < 0.002). No association between self-reported age at menarche and MS was observed by Antonovsky et al. (18) when comparing 131 Israeli female MS cases with 4 times as many female controls matched on age and region of birth. Likewise, in a Norwegian study in 2014, Gustavsen et al. (19) reported similar mean ages at menarche among 391 female MS cases and 535 female controls from the Norwegian Bone Marrow Donor Registry (13.1 years and 13.0 years, respectively).
The discrepant findings are not easily reconciled. Some of the case-control studies suffered from small sample sizes (15, 20) or used suboptimal control groups (15) (16) (17) 19) . The use of neighbors (15), spouses (17) , or friends (16) as controls carries the risk of overmatching; that is, controls may be too similar to cases with respect to potential environmental risk factors and thus may not be representative of the underlying study population. Gustavsen et al. (19) used controls from the Norwegian Bone Marrow Donor Registry, a group of persons who differ from the general Norwegian population with regard to health and lifestyle behaviors; moreover, these controls were on average 6.5 years younger than the MS cases.
Early menarche seems to be associated with more rapid progression of MS (40) . Thus, persons with severe MS (i.e., MS patients with early menarche) might not have survived until study entry in some of the previous case-control studies (15, 18) , which could have introduced bias. In addition, MS patients with more progressive symptoms might choose not to engage in a research study. The difference in response rates between MS cases (70%) and controls (84%) in the study by Gustavsen et al. (19) could indicate that only the most well-functioning MS patients, possibly including a higher proportion of patients with an older age at menarche (40) , participated.
The strengths of the current study include its prospective design, access to detailed information on possible confounders and mediators, and no loss to follow-up. We performed robustness analysis to evaluate any possible impact of the delay between first symptoms of MS and date of diagnosis and found similar results. To account for the fact that the DMSR is considered complete only through 2009, we carried out a second robustness analysis using data from the NPR, which is updated continuously, and found almost identical estimates.
Our study has limitations to consider as well. It included only pregnant women who spoke Danish. All general practitioners in Denmark were asked to take part in the recruitment of pregnant women during the period 1996-2002; however, about 40% of the women eligible for inclusion never received an invitation, and among the invited women, the rate of participation in the DNBC was approximately 60% (41) . According to Jacobsen et al. (41) , who compared participants in the DNBC with the source population in 2 geographical areas of Denmark (North Jutland County and the municipality of Aarhus), groups with low socioeconomic resources in terms of education, occupation, income, and civil status are underrepresented in the DNBC. Women participating in the DNBC are therefore likely to be healthier than women who do not have the resources and capabilities to engage in the DNBC. Furthermore, compared with the general female population, women with MS are more often childless (33) . Consequently, women predisposed to the development of MS might be less likely to participate in the DNBC. Such a potential lack of generalizability to all socioeconomic strata of Danish women and to all female MS patients is unlikely to have affected the internal validity of our study findings. However, our findings based on pregnant women may not necessarily apply to all women. Another important limitation of our study was the limited number of MS cases in some of the strata of menarcheal age, leading to broad confidence intervals. It is reassuring, however, that in the robustness analyses using updated information from the NPR (43 additional cases), the association between age at menarche and MS risk was almost identical to that of the primary analysis.
Age at menarche was assessed retrospectively among adult women. On average, the start of menstruation had happened 16.6 years prior to participation in the DNBC. The correlation between actual and subsequently recalled ages at menarche has been found to be quite good (Pearson's correlation coefficient = 0.8) (42) . However, some level of imprecision in recall of age at menarche probably existed in the present study. We believe that this kind of misclassification would most likely have been nondifferential and therefore would have produced conservative estimates. Nevertheless, to further account for possible recall problems, we performed a supplementary analysis using information on age at menarche recorded in school health records and found fully compatible results, albeit statistically nonsignificant, probably because of small numbers.
Our results did not appear to be confounded by adult socioeconomic status or BMI, nor did alcohol, smoking, parity, or age at first pregnancy seem to act as a mediator in the relationship between menarcheal age and MS. However, because no information on parental socioeconomic status, childhood BMI, and alcohol drinking and smoking habits in adolescence was available, we were not able to account for a possible effect of these factors. In addition, we had no information on variables such as childhood stress and vitamin D insufficiency-factors which also have been suggested to affect both age at menarche (43) and MS (8, 44) .
One can only speculate about the possible underlying mechanisms behind the observed inverse association between age at menarche and MS. A recent genome-wide association study (45) has suggested that hundreds of common genetic variants are involved in the coordinated timing of menarche and that some of these variants also appear to be associated with various immunity-or inflammation-related traits. Thus, common genetic factors leading to both early menarche and possible immune-mediated processes triggering MS might have contributed to our findings as well (46) .
The observed association between age at menarche and risk of MS could also be related to the complex process of maturation of the central nervous system (47) . The delicate development of the nervous system might somehow be disturbed by early menarche or conditions associated with early menarche, such as exposure to potential environmental risk factors for MS at a younger and more vulnerable age. Another mechanism could be that exposure to certain environmental risk factors in early life may cause premature activation of the hypothalamic-pituitary-gonadal axis, leading to hormonal imbalance, early menarche, and dysregulation of the immune system and thereby an increased risk of autoimmune diseases such as MS (17, 48) .
In conclusion, our cohort study showed an inverse association between age at menarche and risk of MS, with a 13% reduction in MS risk per 1-year increase in age at menarche. However, the underlying biological mechanisms explaining this association remain unclear.
